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I. Introduction 
Over the past several decades, the general topic of acute 
renal failure has continued to attract interest and stimulate 
investigation. This is, in part, a reflection of the many 
clinical entitles that can result in an acute renal debacle and 
an Incomplete understanding of their role in the production of 
the renal lesion. Despite intensive effort of investigation, 
the pathophysiology of nonspecific* acute renal failure (ARF) 
is still uncertain. While some Investigators emphasize tubular 
necrosis, others see vasoconstriction as the principal cause of 
renal failure. Both animal models and studies of patients exist. 
The animal models have the advantage that extensive data are 
available from direct technics such as micropuncture. Although 
evidence from studies of patients is fragmentary and indirect, 
it is worth attention because of the uncertain relevance of 
animal models to human acute renal failure, especially the 
common post-ischemic type. 
♦Acute renal failure from specific causes, such as glomerulo¬ 
nephritis, vasculitis and Interstitial nephritis etc., are not 
considered in this thesis 
. 
. 
A. Observations in animal models 
Acute renal failure (ARF) has been induced in rats and 
dogs with a number of modelst (1) nephrotoxins such as mercury* 
dlchromate and uranyl nitrate; (2) pigments Including myoglobinuria 
from muscle injury with glycerol, hemoglobinuria and methemo- 
globinuria; (3) ischemia Induced by temporal occlusion of the 
renal artery, and by intrarenal infusion of vasoconstrictors. 
From these models, several mechanisms have been postulated to 
account for the oliguria in ARF : (1) passive back diffusion 
of the glomerular filtrate through a damaged tubular epithe¬ 
lium; (2) obstruction of the tubules by casts or edema; (3) a 
severe reduction in glomerular filtration rate due to such 
causes as preglomerular vasoconstriction; a decrease in glo¬ 
merular plasma flow; or an alteration in the ultrafiltration 
capillary membranes (KF). The situation becomes particularly 
complex in several of those experimental models in which 
more than one abnormality exist. 
1. Leakage of Filtrate across damaged tubular epithelium 
According to the "passive back flow" theory of the patho¬ 
physiology of ARF(77), glomerular filtrate is formed at a normal 
or only slightly reduced rate but is quantitatively reabsorbed, 
quite passively, across injured epithelium which can no longer 
serve as an effective absorption barrier. This theory has 
enjoyed wide acceptance in the past and is still frequently 
cited as a major determinant of renal Insufficiency. 
Among the earliest proponents of tubular injury as the 
basis for oliguric renal failure, Richards(77) reported in 1929 
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that in the anuric stage of cyanide or mercury poisoning in 
frogs, flow of fluid from the glomerulus into the beginning 
of the proximal tubule was "normal or even Increased." That 
brief report, however, gave no information as to the dose of 
mercury used, the means of determining the rate of glomerular 
filtration (GFR), the number of animals studied, the time 
after injection that studies were performed or whether histo¬ 
logic alterations had indeed been produced. That study did not 
receive much attention. In contrast, Oliver's elegant micro¬ 
dissections (69,70) in the 1950’s documenting structural 
evidence of "disruptive" or "tubulorrhextic" damage to nephrons 
of animals and/or patiente with nephrotoxic and circulating 
ischemic insults. On the basis of his findings, Oliver suggested 
that backleak of glomerular filtrate across damaged tubular 
epithelium accounts for both the oliguria and the renal 
interstitium edema found in these animals or patients. 
That this pathophysiological event occurs in experimental 
ARF in the rat has subsequently been demonstrated by micro- 
puncture techniques. Some investigators have used such 
nephrotoxic chemicals as mercuric chloride or uranyl nitrate as 
the etiologic agent of the renal failure, others have involved 
the use of heme pigments, and still others have employed 
prolonged total renal ischemia. Of all these studies published 
thus far, only a few have incriminated strongly the "passive 
backflow" theory as the major etiological factor in ARF; these 
few studies will be discussed below in more details. 
Bank, Mutz and Aynedjian(8) performed renal micro- 
puncture in rats 24 hours after they were given subcutaneous 
injections of low doses of mercuric chloride (3.0-3.5mg/kg), 
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at a time when almost all animals became anuric• They found 
that intravenously injected lissamine green, which normally 
becomes deeper in color as it traverses the proximal tubule 
(the normal tubule does not reabsorb the dye at all), appeared 
in some proximal tubules of these rats, but became more pale 
with the passage of time. The dye failed to appear at all in 
distal tubule segments visible on the kidney surface. The 
authors interpreted this finding, quite logically, as sign¬ 
ificant leakage of the dye across damaged proximal tubule 
epithelium. In the same study, Bank and co-workers measured the 
single nephron tubular fluid to plasma inulin (TF/P)In ratios 
using micropuncture, and from that, Inulin clearance at three 
sites: early proximal tubule, late proximal tubule, and distal 
tubule. Inulin clearance was found to be normal at the beginning 
of the proximal tubule but fell by more than 60% by the late 
proximal convolutions. It is interesting to note that the upper 
2/3 of the proximal tubule despite this fact showed no disrupt¬ 
ion on light microscopy 24 hours after the low dose of mercury 
used. Furthermore, the suggested "leakage" of 2/3 of the 
filtered inulin from this early proximal tubule became more 
remarkable when only 29% of the inulin remaining was reported 
to be lost from the distal one-third of the proximal tubule, 
the only segment of the nephron displaying frank tubular necrosis. 
Another micropuncture study supporting the passive back- 
flow theory was published by Elsenbach and Stelnhausen(87), 
who reported that an unspecified proportion of inulin Infused 
into individual proximal tubules of one kidney in mercury 
poisoned rats appeared In the ureteral urine collected from 
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both kidneys. This could only occur If the injectate had leaked 
from the tubule Into which It was Injected, recirculated and then 
was filtered. 
Increased inulin permeability has also been noted In the 
uranyl nitrate model in both dog and rat. In an elegant study 
published by Blantz(ll), low dose (15mg/kg) and high dose (25mg/kg) 
of intravenous uranyl nitrate (UN) were administered to Munich- 
Wlstar rats. Using '^C-inulln and the micropuncture technique, 
the (1) total kidney GFR} (2) single nephron gfr (sngfr) at the 
early vs. late proximal tubule were determined in both groups of 
rats, as well as in a control group. In the same study, micro¬ 
injection of 3H-inulin and ,4C-mannitol into proximal tubules were 
performed on a separate control and high dose (25mg/kg) UN group. 
Recovery of both isotopes were measured from the microlnjected 
as well as the contralateral kidneys. Total kidney GFR was 
reduced to 47$ of control in the low dose group and to 21$ in 
the high dose group. The simultaneous single nephron gfr (sngfr) 
measured at the early proximal tubule was found to be essentially 
identical in the control and low-dose groups and reduced only to 
63$ (statistically significant) of control in the high dose group. 
This disparity in UN effect upon GFR and sngfr, with a greater 
reduction in GFR than the corresponding sngfr, was thought to 
be due to tubular back-diffusion of solute through damaged epi¬ 
thelium distal to the early proximal tubule, as demonstrated by 
microinjection of Inulin and mannitol in the proximal tubule. 
Recovery of 3H-inulin and ,ifC-mannltol from the microinjected 
kidney was nearly complete at 9&±1 and 95±2$ respectively, in 
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control rats. However, in the high dose UN treated group, reco¬ 
very of inulin and mannitol from the microinjected kidney 
was 55*10 and 43*8$. Also, significant radioactive material 
was excreted from the contralateral kidney at 7*3 and 12*2$, 
respectively. Total radioactivity excreted from both kidneys 
was less than 100$ after UN because of the very low GFR bilat¬ 
erally, which permitted significant quantities of inulin and 
mannitol, which had leaked from the tubule, to leave the plasma 
volume. In addition, comparlsion of sngfr using wC-inulin, 
measured in early vs. late proximal tubule revealed no differ¬ 
ence after high dose UN, suggesting no significant leak of 
inulin from the early proximal tubule, and that the decreased 
sngfr (63$ of control) at that site was due to primary reduct¬ 
ions in ultrafiltration. A detailed analysis of the separate 
factors which can affect the sngfr showed that total glomerular 
permeability (LpA) was reduced to 53$ of control in the low 
dose group and to 26$ of control in the high dose group. The 
conclusions of this study were twofold; namely UN decreases 
GFR by two mechanisms; (a) tubular damage leading to back-diff¬ 
usion of solutes and (b) a primary reduction in sngfr due to 
reduced glomerular permeability in high dose UN. 
Passive backflow has also been suggested in renal ischemia. 
Arendshorst et al.(2) injected small volumes of lissamine green 
into the proximal tubule of animals 22-26 hours after an hour of 
renal artery clamping. Although intratubular pressure never incre 
ased more than 2 mm Hg, the dye was seen to exit from the tubule 
creating a "halo” effect in the interstitium. This phenomenon did 
not occur in normal tubules. One could possibly still criticize 
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this study by suergestinp- that the small increase in intratubular 
pressure altered permeability in an otherwise friable tubule. 
However, a recent study by Donohoe et al.(31) has obviated that 
possible criticism and clearly shown that tubular permeability is 
increased in the clamp model. Horseradish peroxidase (HRP) (mol¬ 
ecular weight 40,000 and Sinstein-Stokes radius (ESR)=30A), a 
probe molecule that can be cytochemically demonstrated in cells 
or tissue by light and electron microscopy, was dissolved in 
normal saline and was microinjected into both control and 60-min. 
ischemia damaged rat nephrons. This was followed by tissue fixation 
using ficlutaraldeh.yde in sodium cacodylate buffer. Thereafter, 
cortical slices of excised kidneys were immersed in the same fix¬ 
ative for 3 more hours, washed overnight in cold sodium cacodylate 
buffer, and reacted for peroxidase with specific reagents. 
Following Incubation, the purified sections were postfixed in 
osmium tetroxide for 90 minutes, dehydrated, imbedded in Epon, 
and looked under light and electron microscopy. To circumvent the 
criticism that microinjection per se, by raising intratubular 
pressure, may artifically cause transepithelial leakage of 
tracer molecules, the authors repeated the experiment except for 
usinc microinjection of the tracer molecule, they used intravenous 
injection of HRP into 3 rats 1 to 2 hours after 60 minutes of 
renal ischemia, and into 2 rats 1 to 2 hours after 25 minutes of 
ischemia. A control rat was similarly injected. The kidneys were 
then fixed within 5 minutes of injection by intravenous perfusion 
of the same fixative, and the same procedures repeated as 
mentioned above. Results indicated that in the proximal 
convoluted tubules subjected to 60 minutes of ischemia, both the 
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microinjected and the i.v. injected HRP penetrated diffusely 
through the cytoplasm of isolated tubular cells and out into 
the interstitium and capillaries. In contrast, in control proximal 
tubule and in convoluted proximal tubule subjected to 25 minutes 
of ischemia, epithelial cells excluded peroxidase from their 
cytoplasmic matrix, the internal distribution of the tracer 
being confined to phagolysosomes. That such a large protein can 
so readily travel from lumen to interstitium clearly indicates 
that these cells had lost their selective permeability. In the 
same study, 35^ of “*C-inulin microinjected into ischemic proximal 
convoluted tubule was recovered in contralateral urine after 60 
minutes of ischemia; 11% was recovered after 25 minutes; thus 
providing further evidence of tubular backleak of filtrate into 
the Interstitium and circulation. 
2. Tubular Obstruction 
There is no question that tubular obstruction is an impor¬ 
tant pathophysiologic mechanism in various forms of ARF. This 
is especially convincing in the renal artery clamping model. 
Arendshorst and co-workers(2) found a marked increase in intra- 
tubular pressure 1-3 hours after release of total renal artery 
occlusion. Immediately after removal of the occluding clamp, 
RBF rapidly returned to about 50% of normal and the previously 
collapsed proximal convolutions became filled with fluid, 
indicating the resumption of glomerular filtration. However, the 
proximal intratubular pressure rose from 11 to 31 m® Hg, and 
the distal intratubular pressure was also significantly elevated. 
By 22-26 hours after occlusion, intratubular pressures had 
returned to essentially control level. However, the authors 
suggested that this may be due to a decreased GFR caused by 
p 
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increased prgglomerular vascular tone, and not necessarily 
relief of obstruction. Comparable results have been found by 
Tanner and Sophason(89). Furthermore, these latter investigat¬ 
ions performed microdissection studies which consistently 
demonstrated the presence of casts in the distal tubule of 
post-clamp but not control animals. Tanner and Steinhausen(90) 
also examined the pressure-flow characteristics of tubule from 
normal and post-renal artery clamp animals. In the majority of 
ARF tubules, microperfusion at a rate of 15 nl/min led to an 
immediate and marked increase in intratubular pressure to values 
as high as 150 mm Hg followed by a spontaneous fall. The spon¬ 
taneous fall was associated with the appearance of the perfusion 
fluid in the distal tubule. This series of events was never seen 
in tubules of normal animals. The authors concluded that tubular 
obstruction was initially present and that the marked increase 
in intratubular pressure led to venting of the tubule. 
The basis of this obstruction has recently been studied by 
Donohoe and associates(31)* Utilizing histological techniques, 
they found that more than 90% of straight proximal tubules were 
occluded by swollen blebs of desquamated proximal tubular 
microvilli. 
Tubular obstruction has also been noted in some, but not 
all, of the other models of ARF under discussion. Burke et al.(15) 
found a normal to increased intratubular pressure in association 
with a marked fall in nephron GFR in the initial phase of nor¬ 
epinephrine induced ARF in the dog. Previous studies have sugg¬ 
ested that obstruction is not present in the glycerol model in 
view of the low Intratubular pressure(67)• However, a recent study 
by O'Connor et al.(85) have found that intratubular pressure is 
. 
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uniform and normal from 3 to 18 hours after glycerol despite a 
marked reduction in GFB which should tend to decrease intra- 
tubular pressure. Superficial proximal tubules are not dilated 
and casts are usually not seen in the surface nephrons. After 
Ringer loading, however, a modest amount of cellular debris is 
readily seen traversing the collecting duct system and exiting 
from the duct of Bellini. It seems possible that this debris 
may cause partial obstruction to flow in some portion of the 
distal nephron in circumstances in which urine flow is low. 
Alternative explanations for this finding are certainly possible. 
In rats made oliguric with mercury, dichromate or 
methemo?lobin(8,45,54), micropuncture studies show that many 
nephrons have elevated intratubular pressure. In ARF due to 
methemoglobin, the pigment itself is deposited( 5*0 • Flamenbaum 
and associates(37) found significant evidence for tubular 
obstruction in the mercuric chloride model in the rata Normal 
tubular pressure coupled with a markedly reduced nephron GFR was 
demonstrated. When the tubule was vented, GFR was restored to 
normal levels. In contrast, no evidence for tubular obstruction 
has been found in the uranyl nitrate model(11,86). 
In addition to the obvious mechanical effects of tubular 
obstruction, Arendshorst and co-workers(3) have suggested a 
secondary hemodynamic effect of this alteration. Complete 
ureteral ligation of 24 hours duration markedly decreased glom¬ 
erular capillary pressure estimated from the stop-flow pressure 
method. A similar response also occurred in tubules from normal 
kidneys in which an oil-block had been placed for 24 hours. They 
suggested that tubular obstruction eventually led to afferent 
arteriolar constriction with a consequential fall in intra- 
. 
tubular pressure. This phenomenon would seemingly explain 
the eventual reduction in intratubular pressure in the renal 
artery clamp model and possibly other experimental forms of ARF. 
3» Renal vasoconstriction 
A reduction in renal blood flow (RBF) and a rise in renal 
resistance has been uniformly found in the initial phase of the 
glycerol model, renal artery clamping, and in the norepinephrine 
model. Ayer et al.(5). utilizing the xenon washout model, found 
a 19$ decrease in RBF within 10 minutes after intramuscular 
glycerol administration in the rat, which progressed to a 73% 
fall at 24 hours. Similar figures have been reported with the 
hydrogen washout method(19). radioactive microspheres(50), and 
the electromagnetic flowmeter technique(64). Acute Ringer loading 
will reverse the vasoconstriction in the first 3 hours after 
glycerol administration with complete restoration of glomerular 
filtration rate (GFR)(64). 
Arendshorst(2) recently evaluated the effect of 1 hour of 
renal artery occlusion on renal hemodynamics. Thirty to ninety 
minutes after release of the occlusion, RBF measured by electro¬ 
magnetic flow transducer was reduced by approximately 40-50$ 
and renal resistance was reciprocally increased. Similarly, 
Daugharty et al.(27) found approximately a 40$ decrease in whole 
kidney and cortical sincrle nephron filtration rate, after 3 hours 
of nearly complete occlusion of unilateral renal artery. 
Fung(42) and subsequently Knapp and associates!55) first 
demonstrated that the prolonged infusion of large doses of 
norepinephrine would cause oliguric renal failure in the dog. 
When a dose of 0.?5 ug/kg/min of the drug is given in the renal 
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artery, blood flow and urine flow fall to essentially zero and 
remain at this level for the length of the infusion. After dis¬ 
continuation of the drug, there is a slow restoration of blood flow 
which rarely exceeds ^0% of the control value at 3 hours(60). 
If the norepinephrine infusion is given for 2 hours, renal 
function is irreversibly damaged(23)» although recovery will occur 
with a 40-min. infuslon(24). However, in ARF caused by Ischemia 
in rats(2), or by intrarenal norepinephrine in dogs(23), saline 
loading restores RBF to normal or even above normal without 
reversing oliguria. This succcrests that reduced RBF per se does 
not account for the oliguria in the norepinephrine model. Never¬ 
theless, a significant reduction in RBF is a well established 
phenomenon in the initial phase of ARF. 
Within 24-48 hours after the initiation of ARF, alterations 
in RBF do not seem to play a major role in maintaining renal 
function impairment. In the glycerol model, the measurement of RBF 
has been variable in the maintenance phase of the condition. 
Chedru et al.(19) and Ayer & associates!5) have found a 70% dec¬ 
rease in RBF, Churchill et al.(20) found flow to be reduced by 
only 15^. and Hsu and colleagues(50)did not find any change at 
24 hours in this model. Further, O'Connor et al.(64) demon¬ 
strated that Ringer loading could reverse renal vasoconstriction 
18 hours after glycerol without restoring lnulin clearance to 
normal. In contrast, there was a complete recovery of inulin 
clearance 3 hours after glycerol when volume expansion was 
utilized(64). Similarly, as mentioned already, Ringer loading 
can also restore RBF in both the renal artery clamping and 
norepinephrine model 24-48 hours after the insult without a 
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significant return of GFR. 
The findings in the Initial phase of nephrotoxic ARF are 
less uniform. Flamenbaum et al.(38) and Stein & associates(86) 
have both shown in studies in the dog an initial reduction in 
R3F of 5O-60H in the low-dose uranyl nitrate model. In contrast, 
Blantz(ll) utilized even higher doses of the nephrotoxic agent 
in the rat and found no change in RBF. Further, Mauk and asso¬ 
ciates^©) have administered a large dose of prostaglandin 
(a vasodilator) in the renal artery of the dog during uranyl 
nitrate administration and RBF was maintained $0% above the 
control level in 3 hours period after uranyl nitrate adminis¬ 
tration. A marked reduction in inulin clearance still occurred 
which was equivalent to the fall in this parameter in the 
nonvasodHated contralateral kidney. Thus in spite of an increase 
in RBF, a marked fall in inulin clearance still occurred in this 
model. In the do?, blood flow may be reduced in the initial phase 
of mercuric-chloride induced ARF(6). In any case, it seems likely 
from these data that renal Ischemia is not always necessary for 
the development of ARF in these nephrotoxic models. 
In addition, RBF has usually been found to be normal or 
even elevated within 48 hours after administration of these agents. 
Stein et al.(86) found this to be the case in the uranyl nitrate 
treated dog, whereas no change(51) or a modest increase!23) has 
been found in the rat after mercuric chloride. Baehler and asso¬ 
ciates^) noted a marked increase in blood flow after Ringer 
loading in the dog, but oliguria persisted in mercuric chloride 
treated dogs. These studies, therefore, would seem to suggest that 
a reduction in RBF plays little if any in maintaining ARF in these 
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hemodynamically mediated and nephrotoxic models of ARF. 
The precise intrarenal alterations in renal resistance in 
ARF have been a subject of controversy. Some investigators have 
felt that the fall in GFR and urine flow in ARF was disproport¬ 
ionately great for the degree of reduction of RBF and that this 
finding might be due to a combination of marked afferent 
arteriolar vasoconstriction coupled with efferent arteriolar 
vasodllation(7,76). In line with this view, the filtration 
filtration has been found to be reduced in experimental ARF 
as well as in studies in raan(7.76). Yet it should be noted that 
a similar chancre would occur if tubular obstruction or a fall 
in the ultrafiltration coefficient (Kp) was operative in a given 
model of ARF. There is a paucity of direct measurement of afferent 
and efferent resistance in the various experimental models of 
ARF. In this respect, Daugharty et al.(27) studied glomerular 
dynamics after 3 hours of partial renal artery occlusion. Single 
nephron GFR and plasma flow were reduced proportionately, on 
average, by about in association with a proportional rise 
in afferent and efferent arteriolar resistance. Although it has 
been suggested that this model is not truly akin to clinical ARF 
(65). the fact remains that there are all graduations of renal 
impairment in the clinical setting(l). This particular model did 
have the advantage in that the renal cortical surface was homo¬ 
genous and nephron GFR was readily and reproducibly measurable. 
In any case, further studies are warranted to directly measure 
glomerular dynamics in models of ARF. 
The precise pathophysiologic basis for the increase in 
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renal resistance in various forms of ARF Is still unclear. 
One croup proposed that endothelial cell swelling was a self- 
perpetuatincr process induced by renal ischemia and maintained 
by the loss of the ability to retaliate cell volume(39). More 
recently, however, this same group rejected this view because of 
the rapid return of blood flow in the particular model of ARF 
under evaluation(40). 
There has been continuing interest in the possible role of 
the renin-angiotensin system in the regulation of renal resist¬ 
ance in ARF. The next section will further examine this contro¬ 
versial area. In addition, a brief discussion of the role of 
renal prostaglandins in the maintenance of renal resistance in 
these disorders seems in order. 
4. Renin-Angiotensin system and ARF 
Over 30 years ago Goormaghtigh(43) first noted changes in 
the juxtaglomerular apparatus of patients with ARF following 
crush injury. From these histologic changes, he suggested that 
the renin-angiotensin system may be involved in the pathogenesis 
of ARF. Subsequent work by other investigators produced further 
support for this postulate. The demonstration of increased plasma 
renin activity (PRA) in the initial stages of both clinical and 
experimental forms of ARF is also in line with this view(29»56,92). 
Although these observations are consistent with the possibility 
that the renin-angiotensin system is involved in ARF, they do not 
establish an etiological connection between activation of the 
renin-angiotensin system and the subsequent development of ARF. 
Further, it has been shown that PRA may return to control levels 
even though ARF persists. In addition, there are patients known 
to have marked elevations of PRA without the occurrence of ARF. 
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Patients with Bartter's syndrome, chronic vomiters, and cath¬ 
artic and diuretic abusers, as well as many patients with 
congestive heart failure, cirrhosis and ascites, and the nep¬ 
hrotic syndrome, meet these criteria. The primary support for 
this thesis, however, stems from the experimental studies of 
various models, primarily in the rat, in which long-term salt 
loading protects against the development of ARF. This has been 
noted in glycerol-induced myohemoglobinuria(58), mercury(30) 
and dichromate(29) poisoning. In all these models, chronic salt 
loading almost completely protected against the development of 
renal ischemia and filtration failure seen in control water 
drinking rats. McDonald et al. (58) evaluated the course of 
acute renal failure after long-term dietary salt loading in rats. 
Ichikawa and his associates found that neither the administration 
of an angiotensin II inhibitor saralasin or a converting enzyme 
inhibitor SQ20.881 protected against the development of ARF(53)» 
Although these drugs were able to raise RBF 3 hours after glycerol 
administration, neither agent reduced the level of BUN. Oken 
et al.(68) have also demonstrated that neither active nor pass¬ 
ive immunization to angiotensin II significantly affects the 
degree of azotemia or the reduction in inulin clearance seen In 
animals with glycerol-induced ARF. These studies indicate that 
circulating angiotensin plays no direct and important role in the 
pathogenesis of this form of ARF. Although these studies do not 
exclude the possibility that renin release in ARF may have a 
major effect on the renal vasculature at the local site of release 
Independent of circulating angiotensin activity, these findings 
certainly do not strengthen the case for this proposed mechanism. 
5» Renal Prostaglandins in ARF 
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There has been a proliferation of data over the last 
decade concerning the role of prostaglandins in the regulation 
of renal hemodynamics, sodium and water balance. There is now 
unequivocal evidence that the primary renal prostaglandin, PGE2, 
is a vasodilator, and it seems possible that alterations in the 
synthesis and release of this locally produced substance may 
play a role in the hemodynamic alterations which occur in ARF. 
Of possible interest in this regard is a recent study by Torres 
et al.(91) which demonstrated that indomethacin, an inhibitor of 
prostaglandin synthesis, increased the incidence and severity of 
ARF induced by glycerol. Since indomethacin alone has been demon¬ 
strated to decrease RBF, it may be that this alteration was 
mediated through an increase in renal resistance prior to the 
induction of ARF. This phenomenon may be of greater importance in 
models of ARF initiated by renal ischemia since indomethacin had 
no effect in mercuric chloride-induced renal failure* It does 
not seem likely, however, that a deficiency of renal prostaglandin 
production per se was operative in the glycerol model, since this 
same group of investigators found an increase in medullary PGEi 
concentration in the glycerol-treated rabbit. Further studies are 
needed to evaluate the role of renal prostaglandins in the patho¬ 
genesis of ARF. 
6. Decrease in Glomerular Ultrafiltration Coefficient 
A number of recent studies have focused on the change in 
ultrafiltration coefficient (Kp) in ARF. In two recent studies, 
a fall in Kp has been directly documented in experimental models 
of ARF. Blantz(ll), studying the uranyl nitrate model in the rat, 
found that Kp decreased from a control value of O.O89 to 0.047 
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and 0.024 ml/sec/gram kidney wt./mra Hg 2 hours after admin¬ 
istration of 15 and 25 mg/kg, respectively, of the drug. A 
similar reduction in Kp has been noted after gentamicin 
administration by Baylis et al.(9). More indirect evidence for 
a reduction in Kp has been noted in the norepinephrine and 
mercuric chloride models. Cox and associates(23) studied dogs 
with unilateral ARF induced by intrarenal norepinephrine 48 
hours after the insult. RBF was reduced, but rapidly rose to a 
level even greater than that found prior to norepinephrine when 
the animal was volume expanded with Ringer solution. However, 
there was still no urine flow from the norepinephrine infused 
kidney. Examination of the surface tubules revealed they were 
all collapsed, a finding that would seem to be indicative of 
a primary failure of filtrate formation. In considering the 
possibilities that would explain the cessation of filtration 
in the presence of an increase in total RBF, an alteration in 
Kp seemed most likely. In order to further evaluate this poss¬ 
ibility, transmission and scanning electron microscopy were 
performed. With transmission electron microscopy there was loss 
of the normal foot process (podocyte) structure with marked 
fusion detectable in virtually every glomerulus. This was even 
more dramatically demonstrated in the scanning studies. There 
was marked disruption of the normal podocyte structure. The cell 
bodies were unstructured and wrinkled, and it was not possible to 
differentiate the primary and secondary processes as well as the 
terminal foot processes. Similarly, study by Stein et al.(86) 
has shown similar but much less severe alterations in epithelial 
structures 48 hours after uranyl nitrate. It may also be of 
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interest that the total loss of normal epithelial structure seen 
with norepinephrine was associated with cessation of filtration 
while a less severe pathologic change occurred In the uranyl 
nitrate model in which nephron GFR was reduced by only 30%• 
Recently, Baehler and associates(6) evaluated the mercuric chloride 
treated dog and found functional changes quite similar to those 
in the norepinephrine model. 
At present, there is little definitive information on whether 
the change in Kf in any of these circumstances is primarily due 
to alterations in effective capillary surface area or hydraulic 
conductivity. In circumstances associated with vasoconstriction, 
it is easy to visualize how Kp may fall. In this regard, Hornych 
and Richet(49) have shown that angiotensin II causes marked 
constriction and presumably a decrease in surface area of the 
glomerular capillaries. However, Kp has also been shown to fall in 
circumstances in which glomerular plasma flow remains constant 
or even rises (10,91 52 ) . Although one mlp-ht construe ways in which 
the effective surface area for filtration could still fall in 
this setting, it seems more likely that a decrease in capillary 
permeability would be responsible for the fall in Kp in this 
setting. 
7* Biochemical Aspects of ARF 
The pathophysiology which occurs after an ischemic or 
nephrotoxic insult are due to biochemical alterations at the 
molecular level. The sequence of events between the initial bio¬ 
chemical aberration and the observed renal insufficiency are 
undoubtedly complicated, and data on the biochemical basis of any 
particular model of ARF are scarce. Yet, there is apparently a 
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fundamental difference in the sequence of events which lead to 
these abnormalities in these two types of models of ARF. 
An Inadequate supply of oxygen and metabolic substrates to 
renal tissue is the initial, major biochemical aberration in 
ischemic ARF. The proximal tubule is largely dependent on 
oxidative metabolism for generation of adenosine triphosphate(ATP), 
which is required for metabolic transformations such as lipo- 
genesls, protein synthesis, and maintenance of cellular structure. 
Distal portions of the nephron are able to synthesize ATP under 
conditions of limited oxygen availability(44). Therefore, energy 
dependent functions of the proximal tubule will be much more 
susceptible to hypoxia than those of the distal nephron. The 
number of anhydride-bound phosphate groups per adenosine moiety, 
called the energy charge, is the critical indicator of the state 
of the cell rather than ATP alone(4). Ischemic ARF probably 
decreases the energy charge such that cellular homeostasis is lost. 
A loss of cell viability and eventual necrosis will accompany a 
large decrease in energy charge. Reversal of the initiation of 
ischemic ARF will only occur if the energy charge remains above 
the level necessary for cell viability. 
An initial decrease in RBF is not necessary for the develop¬ 
ment of renal functional impairment in nephrotoxic ARF, as noted 
previously. Rather than a generalized phenomenon such as a 
decrease in energy metabolism, a specific cellular insult related 
to the properties of the particular nephrotoxin may also be 
operative in this setting. Consider the model of mercuric chloride 
induced ARF. 
Mercurial compounds react readily with sulfhydryl groups on 
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proteins, inhibit the activity of many enzymes, and affect 
numerous cellular processes(93)• Organic mercurials have been 
shown to alter the transport of dyes and calcium in the flounder 
renal tubule(81). In mercuric chloride induced ARF(9^) in rats, 
active transport of sodium and potassium decreased and an 
increase in passive leak occurred. It was suggested that mercaptid 
formation between the mercurials and sulfhydryl groups of plasma 
membrane proteins altered the permeability of the cell. Recent 
reports describing the effect of dithiothreitol (DTT) on mercuric 
chloride induced ARF supports the hypothesis that mercaptlde 
formation with protein sulfhydryl groups is an initial step in the 
biochemical mechanism. DTT is a disulfide reducing agent(21) and 
a chelator of metals(22). If DTT is administered 30 min. after 
mercuric chloride injection into rats, the changes in parameters 
of renal function normally associated with ARF are negligible!82). 
DTT also reversed the inhibitory effect of mercuric chloride on 
sodium transport in the toad urinary bladder!82). 
A direct interaction between uranyl nitrate (UN) and cell 
membrane components is also probably the initial step in this 
model of ARF. However, the interaction between uranium salts 
and cellular components is less well characterized than in the 
case of mercuric chloride, especially for mammalian cells. Yeast 
has been used to characterize the interaction and effects of UN 
on intact cells(79»80) . UN does not' readily penetrate the cell 
membrane, but reversibly complexes with phosphoryl and carboxyl 
moieties on the external surface of the membrane. 
8» Synthesis of Experimental Data 
Table 1 summarizes the various factors that are operative 
- 
, 
in the few experimental models under discussion 
Table 1 Summary of pathogenetic factors operative in experimental 
ARF 
Renal Blood Flow 
Model Initial Mainten¬ 
ance 
Tubular 
Obstruction 
Filtration 
Leakage 
Decreased 
Kf 
Glycerol i (D ± ? ? 
Renal artery 
clamping i Q 4 4 
-* 
Norepinephrine l (D 4 ? 4# 
Uranyl nitrate INt N - 4 4 * 
Mercuric chlor 
ide 
i N t 4 4 4# 
Symbols:t. increased blood flow? N , normal blood flow; decreased 
blood flow; (D, models in which blood flow is reduced but 
can be markedly increased without restoration of inulin 
clearance; 4, mechanism operative in a given model; ?, mech¬ 
anism not evaluated adequately; -, mechanism not operative 
in a given model; *, only evaluated with Incomplete clamp¬ 
ing; #, indirect evidence for a fall in Kp ; t, direct 
evidence for a fall in Kp. 
Several comments should be made concerning this summary. 
As noted earlier, blood flow is reduced in both the initial and 
maintenance phase in all three hemodynamic models. However, a 
restoration of RBF with Ringer solution in the period of fixed 
renal failure does not cause a significant rise in GFR as measured 
by inulin clearance. In the nephrotoxic models, blood flow is 
more variable and there seems to be definite situations in which 
renal ischemia is not necessary for the development of ARF(60). 
Thus, renal ischemia does seem to be a common denominator in the 
hemodynamic but not in the nephrotoxic models. In addition, other 
factors must be involved in the maintenance of ARF in all of these 
experimental maneuvers. In the last three columns we have 
attempted to delineate what these factors may be. Surprisingly, 
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the glycerol model seems the most confusing. Although it has 
been assumed by others that renal vasoconstriction is also 
Important in the maintenance period of glycerol-induced ARF(66), 
O'Connor and associates(64) have shown that Rincrer loading will 
restore blood flow without return of GFR 18 hours after glycerol. 
Although incomplete tubular obstruction in the distal nephron may 
also be present, this does not seem to be the total explanation 
for the functional renal impairment. In the remaining models, two 
or all three of the other identified pathogenetic factors seem to 
be operative in some stage of ARF. 
With these data in mind, Fig. 1 summarizes the current view 
of the pathogenesis of ARF. The initiating event is either renal 
ischemia or the administration of a nephrotoxic agent. Although 
this later intervention may cause renal functional impairment 
without a change in blood flow, hemodynamic alterations may also 
occur. The eventual alteration in renal function will then be 
determined by the severity and specific type of renal insult and 
the various poorly characterized modifying factors which may either 
Increase or decrease the sensitivity of the nephron to the 
particular insult. This will lead to a variety of biochemical 
alterations in cellular function and integrity which will be 
expressed by the various maintenance factors designated in the 
figure. 
INITIAL PHASE Renal ischemia f Nephrotoxic 
Flg.l Summary of 
• MAINTENANCE 
PHASE 
pathogenesis of 
ARF 
Prolonged Tubular 
Vasoconstrict- age of 
l Leak- Tubular Decreased 
Filtrate 
Obstru- Glomerular 
ction Permeability 
. 
Last of all, a comment should be made concerning the 
similarity of these models to the clinical setting. Although it 
is obviously difficult to extrapolate the findings in these models 
to clinical ARF, we feel that several of these models are 
similar in a number of respects. For instance, the glycerol 
model is, in a number of respects, analogous to the "crush syn¬ 
drome” seen after trauma of various types in man. Further, it 
should be recognized that clinical ARF may encompass a wide range 
of renal functional impairment. Thus, the partial renal artery 
clamping model described by Daugharty et al.(27) may indeed be 
analogous to a less severe form of ARF in which reversal of the 
functional impairment is prompt. In any case, I feel that these 
models are powerful tools for the study of ARF and that their use 
has greatly increased our knowledge in this field. 

B. Observations in man 
A knowledge of certain aspects of the pathology of acute 
renal failure (ARF)(46) in man is vital for an understanding of 
pathogenesis. The histologic picture differs greatly between 
post-ischemic failure and nephrotoxic failure. In nephrotoxic 
injury, damage to tubular epithelium is prominent and relatively 
uniform, especially in the proximal convolutions. In post-ischemic 
failure, epithelial-cell damage is most often focal or patchy. 
When present, necrosis may occur in any part of the tubule, but 
it is most frequent in distal tubular segments, especially in the 
cortlcomedullary junction. Proximal tubules are often dilated and 
lined with flattened epithelium, but necrosis is uncommon. 
From the pathogenetic point of view, the most striking 
bettfeeN 
feature of post-ischemic ARF is the poor correlationAhistologic 
changes and functional severity. The focal and often minimal 
damage to tubular cells contrasts to the severe impairment of 
renal function. For example, Flnkh et al.(35) compared coded 
specimens from patients with clinically definite ARF with speci¬ 
mens from control patients who had died without any evidence of 
impaired renal function. Histologic evidence of tubular damage 
was often slight and occasionally absent in the specimens from 
patients with renal failure. Similar histologic changes were 
occasionally present in the control specimens. The histologic and 
clinical features did not show the degree of correlation to be 
expected if tubular cell necrosis were a critical part of the 
mechanism of renal failure. Such observations have led many invest¬ 
igators to believe that functional changes such as vasoconstriction 
are the principal factors. However, subtle damage to intracellular 
organelles may be noted on electron microscopy(26) in cells that 
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are not overtly necrotic, and biochemical damage may be even 
more widespread. Thus, although histologic observations make it 
unlikely that necrosis per se is the key mechanism, they do not 
rule out functionally important cell damage. Routine histologic 
studies of tubules in the cortex do not suggest widespread tubular 
obstruction by intraluminal debris. However, limited observations 
(72) suggest that casts, possibly composed in part of Tamm- 
Horsfall mucoprotein, may be more prominent in the medullary 
collecting ducts. (Tamm-Horsfall mucoprotein is a component of 
normal urine that is readily precipitable in vitro under cond¬ 
itions of flow and urinary composition that might be expected in 
the collecting ducts of hydropenlc subjects(72).) The dilatation 
of proximal tubules described above may also be attributable to 
obstruction in more distal segments. With reference to reduction 
of renal blood flow or glomerular filtration as primary patho¬ 
physiological mechanisms, it is noteworthy that the blood 
vessels and glomeruli appear normal on light and electron micro¬ 
scopy (26,71,25) in human ARF. 
The pathological features of post-ischemic ARF in man cast 
some doubt on the relevance to human disease of the experimental 
models that have been studied most carefully. Models in which 
nephrotoxins such as mercury or dichromate are used to Induce 
ARF presumably are pertinent to nephrotoxic failure in man but 
are probably less valid for predicting mechanisms in human 
post-ischemic failure. Complete occlusion of the renal artery 
has been studied extensively as a model of the latter. However, 
cell damage is much more severe and diffuse after arterial occl¬ 
usion in rats(31»2) than in typical post-ischemic ARF in man 
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(46,33)* Other ischemic models(23) induce glomerular changes 
not found in specimens from patients with acute renal failure. 
These differences in no way deny the value of careful studies of 
experimental models. They do suggest the importance of validating 
experimental hypotheses derived from animals by studies of 
patients whenever possible, despite the limitations imposed by 
ethical and practical considerations. 
Renal vasoconstriction persists throughout the period of 
renal failure in patients with ARF. Total renal blood flow (RBF) 
is usually between £-•§■ of normal, as estimated by a variety of 
methods, such as dye dilution and inert-gas washout(63»4?)• On 
angiography, the cortical arterial vessels are narrowed or not 
Visualized, and the cortical nephrogram is absent. The fast, 
"outer cortical" component of inert-gas washout curves disappears 
or is markedly slowed(47). These changes have been observed both 
in ischemic and in nephrotoxic ARF(48). From these studies, 
Hollenberg and his associates(47) have inferred that severe, 
sustained preglomerular vasoconstriction is the pathogenetic final 
common pathway in all forms of human ARF. Observations of Reubi 
et al. in patients with post-ischemic ARF led them to a similar 
conclusion(75)• These investigators used a multiple indicator- 
dilution technic to estimate the volumes of the vascular, inter¬ 
stitial and intratubular components of the kidney. They reasoned 
that, if glomerular filtration were abolished, the distribution 
volume of their marker of tubular ♦ interstitial/vascular (2^Na) 
would be decreased, because the 24Na would be denied access to 
tubular lumens. On the contrary, if glomerular filtration were 
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preserved but tubular cells had become leaky to filtrate and 
large molecules, the distribution volume of their index of 
vascular/interstitial volume (5,Cr-EDTA) would increase and 
approach that of 2y,Na. Their results were consistent with the 
hypothesis that glomerular filtration is suppressed. As mention¬ 
ed earlier, RBF during the oliguric phase was about ^ normal. 
Thus, the suppressed filtration could, at least in part, be due 
to afferent arteriolar vasoconstriction. Plasma renin activity 
(PRA) is increased in most patients with ARF during the period 
of renal Insufficiency and returns to normal as renal function 
improves(14). These data fit with the hypothesis that angiotensin II 
is the cause of persistent vasoconstriction, although they 
obviously do not separate cause and effect. 
Some observations in -patients do not fit very well with the 
concept that renal vasoconstriction and suppressed filtration 
are the principal causes of renal failure. During infusion 
urography, a nephrogram appears promptly and is of normal intensity 
in most patients with ARF(l6). Iodinated contrast mediums are 
excreted by filtration and are not reabsorbed; the nephrogram is 
due to collection of the contrast material in proximal convolut¬ 
ions (41) . Hence, as pointed out by Fry and Gattell(16,41) the 
early and intense nephrogram suggests that glomerular filtration 
is not greatly suppressed in patients with ARF. Moreover, the 
nephrogram usually persists unchanged for hours or even days. In 
oliguric patients, little or no contrast is being excreted, and a 
pyelogram does not develop. Thus contrast is entering the tubules 
by filtration but not leaving in the urine, yet the nephrogram 
usually does not become increasingly dense. To account for this 
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finding, Fry and Cattell suggest that contrast material may be 
leaking back through damaged tubular epithelium. Although these 
observations are of considerable interest, it is well to 
remember that the intensity of a nephrogram can only be estimated 
semiquantitatively. From these data, therefore, one can only 
infer with confidence that filtration is occurring at a subs¬ 
tantial rate, not that the filtration rate is normal. Moreover, 
studies in rats with experimental ARF show the same radiologic 
phenomena, and yet analysis of renal failure demonstrates that 
the amount of contrast medium in the kidney is substantially 
less than in controls(78). This finding indicates that a normal 
appearing nephrogram is not proof of a normal rate of filtration 
of contrast medium. Despite these caveats, radiologic observat¬ 
ions do not fit well with the hypothesis that vasoconstriction 
and suppressed filtration are the key factors causing oliguria 
in human ARF. Another type of observation also poses problems 
for this hypothesis. Infusion of vasodilators such as hydralazine, 
acet.ycholine( 57) and prostaglandins( 74 ) into the renal artery 
markedly increases renal blood flow in patients with ARF, and 
yet oliguria persists. These observations are similar to those 
in a number of experimental models, as described earlier. One 
can explain them by postulating a combination of afferent arteri¬ 
olar vasoconstriction and efferent arteriolar dilatation in 
ARF. In that event, vasodilators might restore blood flow by 
efferent dilatation without restoring glomerular filtration 
pressure to normal(75)» There is no direct evidence for this 
hypothesis, however; it is merely an ad hoc assumption to avoid 
the necessity of discarding vasoconstriction as the key patho¬ 
genetic mechanism in human ARF. 
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C. Purpose of the thesis 
In the foregoing- discussion of experimental ARF, the 
pathophysiological event of backleak of glomerular filtrate 
across damaged tubular epithelium has been convincingly demon¬ 
strated usinc raicropuncture techniques in a number of animal 
models. Both ischemic or nephrotoxic insults appeared to have 
the potential of establishing this kind of tubular dysfunction. 
Whether a similar mechanism operates in human ARF is still 
unknown. To test this hypothesis in human ARF, we tried to 
determine the fractional clearances (sieving coefficients) profile 
of dextran in patients with hemodynamically mediated ARF. 
Dextran-40 (Rheomacrodex ) is a homologous series of neutral 
macrosolutes-dextrans- of varying molecular molecular weight 
and size (average molecular weight M.W.-40,000; Einstein-Stokes 
c 
radius (ESR) from 20-57 A). Like inulin, dextran has the properties 
of neither secreted nor reabsorbed by the normal tubule, so that 
its fractional clearance (= clearance of dextran/clearance of 
inulin) can be equated with the concentration ratio of dextran 
in Bowman's space to plasma (BS^/P^). The concentration of a 
particular dextran species D^. of ESR r^ in Bowman's space would be 
expected to vary inversely with ESR, larger molecules being 
more restricted from the Bowman's space because of the size- 
permselectivity properties of the glomerular barrier(l?»l&)• 
The other important determinant of the fractional clearance of 
a macrosolute is the single nephron glomerular filtration rate 
(sngfr), the rate itself being determined by several physiological 
variables as well as the permeability properties of the glomerular 
membrane. Several studies have shown that the Bowman's space-to- 
plasma concentration ratio of a macromolecule should, in general, 
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depend inversely on sngfr(l8). The effects of individual deter¬ 
minants of sngfr on fractional clearances of dextran have been 
well studied in the normal Munich-Wistar rat(13t17»18). These 
determinants are: (1) mean transcapillary hydraulic pressure 
difference, aP; (2) initial glomerular plasma flow rate, QA; 
(3) systemic (afferent arteriolar) plasma protein concentration, 
CpA; and (4) glomerular capillary ultrafiltration coefficient, Kp . 
If it is assumed that in ARF the transglomerular permeation of 
dextrans is the same as that of the normal controls (the validity 
of this assumption and the reasoning behind it will be discussed 
in Methods and Discussion), i.e. the fractional clearances of 
dextrans as would be determined from the fluid in the Bowman's 
space of the ARF patients (if indeed we could sample the glomeru¬ 
lar filtrate under those circumstances) should be the same as that 
of controls. That being the case, no perturbation of transport 
dynamics could possibly account for values of fractional clear¬ 
ances of dextran (0^) above unity, unless the observed urinary 
inulln clearances in these ARF patients as determined by the 
standard method G =VU xUfN /PIN is less than the true inulin 
clearance (i.e. GFR), a situation that could arise if there is 
tubular damage in ARF permitting backleak of inulin. Based on 
this assumption, and relating the observed fractional clearances 
profile of dextrans ("apparent" sieving coefficients) obtained 
from the ARF patients with that of normal controls, one could 
estimate the amount of backleak of Inulin in the damaged tubules 
in human ARF using mass conservation mathematical models. This 
thesis attempts to provide an answer to that issue. 
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II. Methods 
Rationale. In the normal kidney, inulin and uncharged dextran 
molecules with Einstein-Stokes radii (r) up to 44 A are excreted 
by glomerular filtration, and neither secreted nor reabsorbed 
(17,18). While inulin (ESR=13»5 A) is freely filtered, restriction 
to filtration is evident for dextran molecules of ESR=22 A and 
greater. The glomerular fractional clearance or sieving coefficient 
(6$) for a dextran molecule (D) of a specific size i can therefore 
be determined from its fractional urinary clearance relative to 
(ft 
lnulin(13)» Employing polydisperse dextran 40 (Rheomacrodex , 
o 
Pharmacia Fine Chemicals, Uppsala, Sweden, ESR=20-57 A), we 
determined the fractional dextran clearance profile (or glo¬ 
merular sieving curve) in 7 healthy volunteers. As seen in Figure 
1, when fractional clearance values for narrow dextran fractions 
in these volunteers are plotted as a function of ESR (r) of the 
dextran, measurable restriction to dextran (B^<1»0) increases 
O 
with molecular size from r=22 to 40 A• 
Glomerular permselectivity to dextran molecules in ARF might 
differ from that in healthy subjects due to altered glomerular 
capillary hemodynamics and a reduction in the glomerular ultra- 
filtration coefflcient(13,13A,17)• No alteration in glomerular 
transport dynamics could, however, possibly account for values of 
above unity, a finding which we observed for lower molecular 
weight dextrans (r=22-28 A) in 7 of 10 consecutively examined patients 
with ARF. This finding can only be reconciled if the urinary 
inulin clearance is less than the true glomerular filtration rate 
(GFR). This situation could arise if tubular damage permitted tubular 
backleak of inulin into the peritubular space. If it is assumed 
that in ARF either the permeability properties of the glomerular 
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capillary wall are identical to those of the normal glomerulus, 
or any increase in transglomerular permeation of macromolecules 
due to reduced plasma flow(12,17) is compensated by a decrease in 
the glomerular ultrafiltration coefficient(17), then the normal 
dextran sieving curve may be used for estimating "true” sieving 
coefficients of filtered dextrans in Bowman's space in ARF. Based 
on this assumption and employing the measured "apparent" sieving 
curve obtained in ARF and mass-conservation constraints, we 
estimated the backleak of inulin from damaged tubules in human 
ARF. 
Patient Population. Ten consecutive patients developing ARF foll¬ 
owing open heart surgery and 2 groups of control subjects were 
studied using a protocol and consent procedure that had been 
approved by the Committee on the Use of Human Subjects in Research 
at Stanford University. This discrete variety of ARF was chosen 
because it is hemodynamically mediated and usually accompanied 
by a high rate of urine flow. ARF, identified by the sudden onset 
of azotemia, became manifest within 24-48 hours of surgery in 
7 patients. In these patients the ischemic insult was thought to 
have been delivered during the surgical procedure, the magnitude 
and difficulty of which was reflected by a nearly two-fold 
prolongation of cardio-pulmonary bypass time (160±29 min. (mean 
± standard error)) above the institutional average. In the 
remaining 3 patients ARF developed between the 3rd and 5th post¬ 
operative days in the wake of a prolonged low cardiac output 
syndrome and superimposed discrete hypotensive episodes. Clearance 
of macroraolecules (dextrans) was performed when ARF had been 
established for at least 48 hours and prior to initiation of 
dialysys therapy or resolution. During this period, average 
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serum creatinine concentration rose from 1.5*0.01 to 4.5*0.4 
mg/100 ml, while the corresponding values for blood urea nitrogen 
were 24*3 and 88*6 mg/100 ml, respectively. 
Seven healthy male and female volunteers aged between 20 
and 65 years comprised a normal control group. Twelve patients 
with a maximum postoperative serum creatinine <2 mg % following 
open heart surcrery served as cardiac surgical controls. Age (44 
to 77 years), sex distribution (9 male, 3 female), and cardiac 
performance (average cardiac index=2.64*0.13 L/min/Mz) were 
similar to those in the ARF population (Table 1). As a conse¬ 
quence of transient postoperative reduction of cardiac performance, 
GFR was depressed relative to the normal control group (76*9 vs. 
102*5 ml/min/1.73 M1). As can be seen in Figure 1, there was a 
modest elevation of fractional dextran clearance for the dextran 
c 
r range 24-40 A for this group relative to normal controls (P<0.05)» 
This Increase in transglomerular passage of dextrans is probably 
attributable to depressed renal plasma flow rather than to 
changes in the permeability properties of the glomerular capillary 
wall(12). 
Study Protocol. All studies were performed when the patients were 
hemodynamlcally stable. Sudden changes in blood volume, viscosity 
and oncotic pressure were avoided by withholding infusion of 
packed red cells, hyperoncotic human albumin solution and 
furosemide for at least 6 hours prior to study when clinically 
feasible. During each study, fluid balance was maintained by 
constant infusion of an isotonic dextrose solution. Radial arterial 
pressure was monitored throughout the study via a saline-filled 
catheter, which was connected to a Hewlett Packard pressure 
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transducer (Model HP 1280). Cardiac output was determined by 
injection of indocyanine green through a pulmonary arterial 
catheter with subsequent analysis by a Waters densitometer 
(Model D-400) and Waters Cardiac Output Computer (Model CO-4). 
Inulin clearance was performed by administering a priming 
dose (24 mg/kg) followed by constant infusion which resulted in a 
steady state plasma inulin concentration of 10-15 mg/100 ml. 
Dextran 40 (130 mg/kg, concentration 10% solution) was admin¬ 
istered by intravenous Injection directly following the inulin 
prime. After an equilibration period lasting 60 minutes, three 
timed (20 min. each) urine collections were made and blood was 
drawn at the beginning and end of each collection. Inulin 
clearance was calculated as 
clearancelH = (U/P)IN*V (1) 
where (U/P)IN is the average urine-to-plasma inulin concentration 
4 
ratio and V the average urine flow rate in ral/min. for the three 
collection periods. 
Fractional clearance of dextrans () was determined for the 
first timed collection period as 
Ej> = [(U/P)j,/(U/P)IM] (2) 
where (U/P)lN is the urine-to-plasma dextran concentration ratio. 
Determination of Fractional Inulin Leakage. When renal function 
is normal, all inulin and dextran cleared by the glomerulus 
appearing in the glomerular filtrate'is assumed to appear in the 
urine. It is this assumption which permits estimation of the 
sieving curve for dextran ultrafiltration by the glomerular 
capillary wall(13)« For the kidney in ARF, however, we propose 
that tubular backleak of inulin (and also inulin) occurs; if we 

further assume that such leakage is "passive” (that is, occurs 
solely by ultrafiltration and/or diffusion through the damaged 
tubular epithelium), then the rate of leakage of any such solute 
should be nearly proportional to the concentration of that solute 
in the glomerular filtrate. Under such circumstances, the fract¬ 
ional backleak of inulin (defined as the rate of backleak of 
inulin divided by the glomerular filtration rate) will be constant 
(kjN) and Independent of the inulin concentration in the plasma. 
Precisely the same criteria apply to any dextran species of mol¬ 
ecular size (i), leading to a fractional dextran backleak of k^. 
However, the permeability of the damaged tubular wall to dextrans 
would be expected to be a declining function of the size of the 
dextran molecule: 
kj>u» f<rs,) (3) 
where Vcj,;-f kIN as r* —f t„ i kj,, —■* 0 as rJ)i —-too. 
Simple mass-balance computations on inulin and dextran cleared 
by the glomerulus (see Appendix for details) lead to the following 
relationship: 
0<tpp = 0[(l-k}<)/(l-kIN )J 
- e[(l-f(rs.)/l-klN )] (4) 
where $app is the "apparent" sieving coefficient for the 1th dextran 
based solely on plasma and urine concentration measurements, 
and 9 is the "true" sieving coefficient of the glomerular 
capillary wall for that dextran. Qualitatively, we can deduce 
from equation (4) that, for large dextran molecules where k^-0, 
(since (1—kIN ) 0), while for small dextran molecules where 
k^=kIW , $app ^ 0. 
Assuming that the dextran sieving curve in Bowman's space 
in ARF Is identical with that in normal controls for the 
-- 
reasons 

given above, equation (^) can be reduced to: 
aw/fc = <l-kw)/<i-kIN) 
= |i/(l-kIK)J-[kw/(l-kIN)] (5) 
Now, klH is a constant for a c;lven subject, whereas k^ is a 
function of . As r^—*rI(s , —*klN ; and as —■»<«, k^-0. 
Hence, the ratio (kdpp/b) should increase with r^ from a value 
of unity (for small r^) to a limiting value of l/(l-k£h) as r^. 
Increases. Since, as r^-^oo, 0--*O, a plot of (&nfp/&) vs 
should permit a reasonably accurate extrapolation to the limiting 
value of (Gapp/fc)-» l/(l-klN). Inasmuch as the "true" GFR is 
simply equal to l/(1 — kxn) times the "apparent" GFR, the glomerular 
filtration rate corrected for tubular backleak of inulin can 
be calculated. 
Laboratory Determinations. 
Inulin clearance determination. For the calculation of inulin 
clearance, inulin concentrations in plasma and urine were 
determined using the autoanalyzer method of Fjelbo and Stamey(36)• 
Figure 4 in the Appendix illustrates the flow diagram of the 
set-up. The method uses the following reagents: 
a. HCL-Ferric Chloride: 7*5 mg FeClj in 1000 ml concentrated HC1. 
b. Resorcinol (Sigma Chemicals Co.): 1.5 gm resorcinol up to 
1000 ml with 95^ ethanol. 
c. Brlj-35 in water to keep the bubble pattern even. 
The reagents were mixed in two long mixing coils before 
sending them to a 80 C heating bath. It circulated in the bath 
for *10 minutes where inulin, a polymer of fructose, was hydrolyzed 
by the HC1 to fructose, which, on reaction with resorcinol, produced 
a yellow color. The yellow color was measured at 480 m/i in the 
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colorimeter. We have found this method to be uninfluenced by 
the presence of dextran. 
Chromatographic Procedures. To determine fractional dextran 
clearance, plasma and urine samples from the first timed coll¬ 
ection were submitted to gel-permeation chromatography on 
Sephacryl S-200 columns. The Dextran-40 (Rheomacrodex ) in plasma 
o 
and urine was separated into narrow fractions (ESR of 2 A range) 
© 
on Sephacryl S-200 Superfine gel medium (Pharmacia Fine Chem¬ 
icals, Inc.), prepared by covalently cross-linking allyl dextran 
with N, N* methylene bisacrylamide• This new kind of gel filtrat¬ 
ion medium combines a highly porous gel structure with excellent 
chemical and physical stability. It was packed in three K 16/100 
Pharmacia columns (Pharmacia Fine Chemicals, Uppsala, Sweden), 
each with the following column characteristics: 
Internal Diameter (I.D.) = 1.6±0.002 cm 
Outer Diameter (O.D.) = 1.925±0.035 cm 
Length of Column (L) = 91» 95 and 91 cm respectively 
Cross sectional area (A) = 2.0 cm2 
Maximum Volume (VMflX) = 200 ml 
Column flow rate (Q) = 35 ml/hour (17*5 ml/cmz-hour) 
With 0.3$ saline as eluant (0.05$ trichlorobutanol added 
to prevent microbial growth), 2.6-ml eluted fractions were 
collected with an automatic fractionator (Gilson). The void 
volume (Vc) for the individual columns were determined with 
blue dextran, and the results were as follows: 
Column A Column B Column C 
Vt * 180 ml 185 ml 180 ml 
Vo « 61 ml 65 ml 64 ml 
-38- 
■ 
where Vt is the total volume of the gel column and V0 the corres¬ 
ponding void volume, i.e. the volume between the swollen Sephacryl 
particles. 
Calibration of Columns. Calibration curves of the partition 
coefficient (kav) (or the fractional volume available to the solute) 
vs. molecular weight were determined using known molecular weights 
of Dextran T-fractions, namely T-10 (average molecular weight (M.W.) 
=9,400, SSR (r)=22.8 A), T-40 ( M/W .=41,000, r=45*l A) and T-70 
_ C 
(M.W.=67,000, r=56.9 A). A linear relationship was obtained between 
the partition coefficient kav and log)CM.W.. The kav of each narrow 
dextran fraction was calculated using the equation 
kav = (Ve-V0 )/(Vt-V0 ) (6) 
where is the elution volume of the solute (dextran fraction). 
Einstein-Stokes radii (r) for individual dextran fractions 
were calculated using the equation 
r( A) = 0.33 .MTw (7) 
where M.W. is the average molecular weight of that dextran fract¬ 
ion as determined from calibration curves (k^v vs. M.W.) (un¬ 
published data, personal communications with Pharmacia AB, 
equation (7) is valid for dextran of type B 512). 
The calibration results for each column were tabulated below. 
Figures (1), (2), and (3) in the Appendix were the calibration 
curves respectively. 
Column A: M.W. Elution volume (Ve). ml kav/ 
97^00 124.0 0.529 
41,000 87.9 0.226 
67,000 770 0.137 
Column B: M.W. Elution volume (Ve). ml k#v 
97^00 119.6 0.455 
41,000 85.8 0.173 
67,000 78.0 0.108 
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Column C : M.W. Elution volume (Ve). ml k 
9,400 117.0 0.457 
41,000 85.8 0.188 
67,000 75.4 0.096 
For separating the dextrans in the urine and plasma into 
c 
narrow (2 A) fractions, a 2-ml protein-free filtrate of the first 
timed urine collection and a 2-ml protein-free, equal volume 
mixture of the two plasma samples drawn at the beginning and end 
of that urine collection were applied to the same Sephacryl S-200 
column consecutively. Protein-free filtrates of plasma were 
prepared by adding 1 ml of 10$ ZnSO^ solution, 1 ml of 0.75 N 
NaOH solution, 1 ml of plasma to 2 ml of 0 saline to obtain 
a 1:5 dilution, followed by centrifugation and decantation. 
Protein-free filtrates of urine were prepared in a similar manner, 
but were diluted in such a way as to bring the urinary dextrans 
concentrations into range with the dextran standards. This could 
be anywhere from a 1:5 to 1:200 dilution, depending on the urinary 
concentration of dextran. The first 31 eluted fractions (corres¬ 
ponding to the first 31x2.6 ml = 80.6 ml) coming of the chroma¬ 
tographic column were discarded, while fractions #32-61 were 
collected for dextrans and inulin analysis (see below). The 
partition coefficients (k<xv) of the eluted fractions from each 
individual column were calculated using equation (6). The average 
molecular weight (M.W.) of each fraction was then determined from 
the calibration curves of figures (1), (2), and (3) in the 
Appendix. The Einstein-Stokes radii (r) of each fraction could 
then be calculated using equation (7). 
Dextran and inulin concentrations analysis. Dextran and inulin 
concentrations of the eluates (fractions #32-61 of both urine 
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and plasma) were determined using a modification of the 
Autoanalyzer anthrone method of Scott and Melvin(83). Figure (4) 
in the Appendix illustrates the flow diagram of the set-up. 
The reagents used had the following composition: 
a. 1.0 gram of anthrone per liter, of 75^ (v/v) concentrated H2SO4 
+ 2.0 ml of Brij-35 Per liter of solution 
b. 3.0 ml Brij-35 Per liter of deionized water. 
The processing rate was 40 samples per hour with a 1:1 
(30 sec) ratio for aspiration and washing time. After mixing 
with the anthrone and H2SO4, the sample was conveyed to a delay 
C 
coil at 95 C where it circulated for 10 minutes during which 
time the dextran was hydrolyzed by the H2SC>4 and the glucose 
produced reacted with anthrone to give a green color. After a 
short cooling in a mixing coil, the color was measured at 625 nm 
in a 15 mm flowcell of 0.05 volume. This method is best appli¬ 
cable for assaying dextran concentration in the range of 0-100 
,/tg/ml, and for that reason the working standards of dextran 
therefore range from 1 to 80 lts^/ml. Figure (5) illustrated the 
eluted fractions of a solution containing 100 mg£ Dextran 40 
and 50 mg$ inulin coming off the chromatographic column and then 
subjected to the anthrone assay. First came the early dextran- 
containing fractions (#1-14), while the smaller inulin molecules 
(r=ll-17 A) appeared in late eluted fractions (#17-26). A 
separate set of inulin standards were used for assay of these 
inulin concentrations. It should be mentioned that chloride ions 
interfere with the anthrone method. As stated earlier, the eluted 
fractions of the plasma and urine all contained chloride because 
of the saline eluant. To compensate for this chloride interfer¬ 
ence, the dextran and inulin in the working standards were also 
>' -i 

dissolved in O.3-I saline. In addition, since inulin is a poly¬ 
fructose, it would also be hydrolysed by sulfuric acid, and the 
fructose produced also reacted with anthrone to give a similar 
colored compound like dextran. Hence, in order to avoid the inter¬ 
ference from inulin, only the fractional clearances (sievinc 
coefficients) of dextrans corresponding to ESR of 20 A or greater 
would be presented. 
Miscellaneous. Urine and plasma sodium concentrations were meas¬ 
ured using standard flame photometry. Urine and plasma osmolalities 
were determined by the freezing-point depression method. 
Statistical Methods. All results are expressed as the mean and 
standard error of the mean. Student's t test for unpaired data 
was used to evaluate differences between the experimental and 
control croups. 
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III. Results 
The results of 10 studies during the course of established 
ARF are compared with those of 12 nonazotemic postoperative 
control patients in Table 1. The profound depression in renal 
function is indicated by the inulin clearance, which averaged 
10 4 2 ml/min/1.73 M2, a value corresponding to only 13^ of that 
in control patients (?6 ± 10 ml/min/1.73 M2). Only one patient 
was oliguric (V = <T 0.5 ml/min); urine flow averaged 1.9 * 0*4 ml/min 
in all 10 studies. Elevation of fractional sodium excretion 
relative to control patients (7*9 * 2.1 vs. 1.4 ± 0.4$), 
isosthenuria ( U/P osmc La 111 y 1.05 ± 0.03), and a low urine-to- 
plasma inulin concentration ratio (7 ± 1) are all consistent 
with the diagnosis of nonoliguric ARF(62). That this ARF was acutely 
unresponsive to correction of prerenal factors is suggested by 
persisting depression of inulin clearance at a time when cardiac 
index (2.40 ± 0.19 vs. 2.64 ± 0.13 liters .min'1 .m’2) and mean 
arterial pressure (75 * 3 vs. 81 ± 1 mm Hg) were not signifleantly 
different from corresponding values in control patients who had 
near normal renal function. 
In Fig. 1 the mean measured fractional clearances of dextran 
for ARF subjects, normal subjects, and postcardiac surgical 
controls are plotted as a function of Einstein-Stokes radius, r~ 
VL 
0 
interval 20-40 A. As can be seen, the fractional clearance profile 
(0dpp) in ARF subjects was strikingly elevated above that of both 
control groups. When compared to normal subjects, elevation of Gxpp 
was highly significant at the P40.005 level for all dextran 
fractions ^>22 A. The level of significance for 0app vs. 9 of 
cardiac surgical controls over the same range varied from F<0.02 
to P<0.001. In contrast to both groups of controls in whom 
-4^.--- - -■ 

restriction to dextrans with r - 22 A or greater was evident, 
0 
Bapp remained at or above unity for the dextran r interval 20-28 A 
in ARF. Table I in the Appendix is a tabulation of the fractional 
c 
dextran clearances from r = 20 to 40 A in the patients with ARF. 
A plot of the ratios of the average values of @app (ARF) to 
B (normal controls) as a function of normal fractional clearances (0), 
is shown in Fig. 2; the correlation is nearly linear in the 
interval 1.0>$>0.2 and the asymptotic value of (Qapp/B) is estim¬ 
ated to be 2.0. Accordingly, approximately 50% of the filtered 
load of inulin is lost via leakage from damaged tubules, and the 
true GFR for these patients is about twice that calculated by 
urinary Inulin excretion. By plotting fractional dextran clearance 
profiles for normal controls and the ARF patients on semilogarithmic 
coordinates as a function of dextran r (Fig. 3)* the relative 
changes in 0txpp and 9 with increasing values of r become much 
clearer. As Fig. 3 shows, the 9 vs r^ curves become virtually 
c 
straight lines for values of r^>32 A for both populations, and more 
importantly, parallel each other. This condition corresponds to 
a constant ratio (Bapp/9) of about 2.0, which verifies the compu¬ 
tation that about half the filtered inulin leaks out of the damaged 
tubules. 
Since there was considerable variability between the apparent 
fractional dextran clearance profiles for the 10 ARF studies, the 
data for each study were plotted independently in the manner of 
Fig. 2; and the individual asymptotic values of (Ba.pp/0) were 
computed. The results of these extrapolations are summarized in 
Table 2. The limiting values l/(l-kIN) varied between 1.4 and 3.6, 
indicating that there may be considerable variability in the extent 
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of tubular damage, with the result that transtubular inulin 
backleak, while substantial in all cases, may differ by more than 
twofold aaontr individuals (rancre from 31*72^). True rates of glom¬ 
erular filtration calculated from the product of measured Inulin 
clearance and l/(l-ki^) varied from 6 to 33 ml/min in this 
variety of ARF (Table 2). 
Reexamination of equations (A4) and (A5) (see Appendix) 
reveals that the quantities kj> and kiN represent the rates of 
transport of the ith dextran and inulin across the damaged tubular 
epithelium when compared at equal solute concentrations in the 
glomerular filtrate. The ratio (k^/kin), therefore, may be 
regarded as the "relative permeability" of the tubular epithelium 
to the ith dextran with respect to inulin. Since the precise 
transport mechanism across the tubular wall in ARF is unknown, 
this quantity cannot unambiguously be regarded as a "sieving 
coefficient" for the damaged tubule. Nevertheless, tubular 
morphology(32) and microinjection studies(88) in experimental ARF 
suggest that the transmural passage of inulin is unlikely to be 
restricted. We have, therefore, compared the variation of k^/kiw 
with r-,, and with the sieving curve of the normal fflomerulus. The 
results of such computations and comparisons are shown in Table 3 
and Fig. 3• It would appear that the damaged tubule's relative 
permeability and the normal glomerular sieving curve are nearly 
0 
identical for macromolecules of Einstein-Stokes radii r<28 A, 
but the former declines much more rapidly than the latter for 
o c 
molecules in Einstein-Stokes radius ranee 30 A<r<40 A. This 
observation supports the finding that intraluminal macromolecules 
of the size of albumin (r = 36 A) are virtually unable to escape 
through the tubular wall in ARF(88). 
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TABLE 2 
INULIN LEAKAGE AND CLEARANCES IN ARF 
Pa tient 
* 
1 
1-k. l n 
k + 
in Inul in Cl earance 
"apparent" true 
-ml/min- 
1 1.74 .43 11 .7 20.4 
2 1 .79 .44 13.3 23.8 
3 2.16 
* 
.54 14.5 31 .5 
4 1.98 .49 10.4 20.4 
5 1.74 .43 18.9 33.2 
6 3.6 .72 2.2 5.8 
7 2.5 .60 11.7 29.3 
8 1.53 .35 8.3 12.7 
9 1 .44 .31 7.6 10.9 
10 2.29 .56 4.0 10.0 
Mean 2.08 .49 10.3 19.8 
SEM ±0.20 ±.04 1 .6 3.1 
*1 / (1 -kj J = the 1imiting value of (0 / app 
0) VS 0, and \ = fractional inulin 
1 eakage. 
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TABLE 3 
COMPUTATION OF MEAN TUBULAR TRANSPORT CO¬ 
EFFICIENTS, kD, AND RATIOS (k[/k.tj F0R ARF 
PATIENTS 
II
 
1
 
0.49 * 0. .04) 
r 
A 
0 /0 
app 1-kD kD 
kn/L. D7 i n 
20 1 .05 0.53 0.47 0.94 
22 1 .16 0.58 0.42 0.84 
24 1 .28 0.63 0.37 0.74 
26 1 .34 0.67 0.33 0.66 
28 1 .59 0.79 0.21 0.42 
30 1 .58 0.79 0.21 0.42 
32 1 .70 0.85 0.15 0.30 
34 1 .88 0.94 0.06 0.12 
36 1.96 0.98 0.02 0.04 
38 2.00 1 .00 0.0 0.0 
40 2.00 1 .00 0.0 0.0 
For abbreviations, see text. 

Figure 1: Fractional dextran clearance profile in 10 patients 
with ARF (•), in 7 normal controls (o), and in 12 
post-cardiac surgical controls (#). All results are 
expressed as means and the standard error of the 
mean. 

a
pp
 
Fi gure 2 : Mean fractional dextran clearance ratio (0 /0) as a 
app 
function of normal fractional dextran clearance (0). 
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Figure 3: Fractional dextran clearance profiles are shown for the 
normal kidney (normal controls (o)), and the kidney in 
acute renal failure (•). The lower curve is the calcu¬ 
lated dextran sieving curve for the damaged tubule in 
ARF (A). 
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IV. Discussion 
In order to calculate fractional inulin backleak in ARF, 
we assumed that the fractional dextran clearance profile in 
Bowman's space in these patients resembles that in the urine of 
normal controls. At least three pathophysiological events in 
experimental animal ARF (and presumably in human ARF) could 
influence the transglomerular passage of macromolecules. Two of 
these chansres, renal vasoconstrict ion( 12) and a decline in glom¬ 
erular transcapillary hydraulic pressure dlfference(17) are 
predicted to increase the permeation of dextrans with r 20 A into 
Bowman's space. That renal plasma flow was substantially depressed 
in our patients is suggested by an invariable and often severe 
depression of cardiac index at the time of each study (Table 1 
and Refs. 61 & 73)• Furthermore, low renal plasma flow has been 
demonstrated in other varieties of human ARF(45,75A). In addition, 
tubular obstruction, which appears to be an especially important 
pathogenetic mechanism in the postischemic model of experimental 
ARF, would tend to lower the glomerular transcapillary hydraulic 
difference and so increase the sieving of dextrans across the 
glomerular capillary wall(2,32,89,90). Recent evidence, however, 
indicates that a decline in the glomerular ultrafiltration 
coefficient occurs in both nephrotoxic and ischemic animal models 
of ARF(9.11»23,84). Assuming that the glomerular ultrafiltration 
coefficient also declines in human ARF, the transglomerular pass¬ 
age of macromolecules would be restricted, thus offsetting any 
increase in dextran sieving resulting from altered glomerular 
pressures and flows(17)» Since the net effects of these opposing 
determinants of glomerular permselectivity to macromolecules 

cannot be measured precisely in man, the use of the normal 
fractional dextran clearance profile can obviously provide only 
an approximation of fractional inulin backleak. 
In postischemic models of unilateral ARF in the rat, inulin 
microinjection studies have, in general, indicated a direct 
relationship between the severity of the renal ischemia and the 
decree of transtubular inulin backleak. Negligible inulin back- 
leak has followed prolonged partial renal ischemia or total renal 
ischemia of only 15 minutes duration(28,32); by contrast, only 
36-58'? of microln j ect ed inulin was recovered in the urine from 
kidneys subjected to 60 min. of total ischemia(32,3^* 88). About 
of nonrecovered inulin was excreted by the contralateral 
kidney in these studies, indicating substantial peritubular 
capillary uptake of inulin leaked through the damaered tubular wall. 
Given the indirect method we have used to calculate kIN, it is 
interesting to note that our finding of a 31-72,? transtubular 
leak of filtered inulin in this human variety of hemodynamically 
mediated ARF is in good agreement with that found following 60 min. 
of total renal ischemia in the rat. Similarly, our computed sieving 
characteristics of the damaged tubular wall are consistent with 
the findings from microinjection studies in post-ischemic experi- 
_ C 
mental ARF, in which horseradish peroxidase (r=30 A) was found to 
C 
leak out of damaered tubules(32), while albumin (r=36 A) was 
retained within the tubular lumen(88). Accordingly, our model 
appears to provide data in man consistent with those more 
directly obtained in experimental ARF in animals. 
Glomerular filtration rate, when corrected for backleak 
in our patients with ARF, averaged 20 ml.min*.1.73 M 2, a value 
-53- 

corresponding to only 26& of that in cardiac surgical controls 
with similarly depressed cardiac performance. Therefore, addit¬ 
ional mechanisms must have been operative to explain the profound 
depression of glomerular ultrafiltration. It is possible, for 
example, that renal vascular resistance may have been disproport¬ 
ionately elevated in ARF, resulting in a lower renal filtration 
fraction than in the cardiac surgical controls. In addition, a 
reduction in net srlomerular ultrafiltration pressure (due to 
tubular obstruction) and/or srlomerular ultrafiltration coefficient 
miflrht be invoked to explain the reduced GFR. Since each of these 
observations in the determinants of srlomerular ultrafiltration 
has been demonstrated in post-ischemic experimental ARF, it 
seems reasonable to assume that they provide the basis for that 
portion of GFR depression not accounted for by backleak in 
our patients. 
-54- 

V. Appendix 
For the normal kidney, the rate of tubular inulin and dextran re¬ 
sorption is zero,and mass conservation requires that: 
U. V = GFR . UF. - GFR . P. (A1 ) l n i n l n 
UQ V = GFR ■ ufd. ■ ®D. . GFR • V (A2) i 1 1 l 
where U. V and U n V are the urine excretion rates of inulin and dextrans l n i 
of ith molecular radius in mg/min, respectively; UF.^ and UFp refer to 
i 
the concentration of these solutes in glomerular ultrafi1trate, and other 
symbols are defined as before. Since UF. = P. , it follows that the J in i n 
sieving coefficient (0) for'-the ith dextran is: 
G • ,UF0. ' * <UDt ' Uin> ' <PD. 1 Pin> 
111 1 
(A3) 
For the kidney in ARF, however, if tubular backleak occurs and is assumed 
to be passive (i.e. driven solely by diffusion where the "sink" concen¬ 
tration is negligible), then 
Leak. . = k. . GFR . UF. (0 < k. < 1 .0) in in in in 
LeakD = kQ . GFR . UFQ (0 < kQ <1 .0) 
i i i l 
(A4 ) 
(A5) 
where Leak, and Leak., refer to the rates of transtubular backleak of i n D • 
inulin and dextran in mg/min, respectively, and k. and kp are the frac- 
i 
tions of filtered inulin and dextran lost from the tubule. 
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The damaged tubular wall is presumably permeable to dextrans as well 
as to inulin, but the permeability should be a declining function (f) of 
dextran molecular size (r) that is: 
kD. f ^rD.^ 
i 1 
kn -+ k. asrn -*■ r. ; kn 0 as rn -> D. in D. in D. D. 
i ill 
(3) 
In this case mass-conservation requires that 
U. V = GFR . P. (1 -k. in in in 
UD V - 0D . GFR . PD (1-k ) 
i i i i 
(A6) 
(A7 ) 
and thus 
Un V / U. V = Un / U. = Pn / P. .0 [ (1 -k )/ (1 -k. ) (A8) D. in D. in D. in L D. in v ' 
ill l 
If we now define the "apparent" dextran sieving coefficient as: 
0 = (Un / U. ) / (Pn / P. ) 
app D. in D. in K i l 
(A9) 
then: 
0 =0 [(1 -kn ) / (1-k. )J = 0 [l-f(rn )J / (1-k. ) 
app L D. inJ L UD./J in l l 
(4) 
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